aTYR PHARMA INC Stock Issued During Period, Value, Employee Stock Purchase Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- aTYR PHARMA INC stock issued during period, value, employee stock purchase plan for the quarter ending 2026-06-30 was $16.00K, a 79.75% decline year-over-year.
- aTYR PHARMA INC stock issued during period, value, employee stock purchase plan for the quarter ending 2025-06-30 was $79.00K, a 102.56% increase year-over-year.
- aTYR PHARMA INC stock issued during period, value, employee stock purchase plan for the quarter ending 2024-06-30 was $39.00K, a 40.00% decline year-over-year.
- aTYR PHARMA INC stock issued during period, value, employee stock purchase plan for the quarter ending 2023-06-30 was $65.00K, a 1200.00% increase year-over-year.
- aTYR PHARMA INC stock issued during period, value, employee stock purchase plan for fiscal 2025 was $108.00K, a 8.00% increase from fiscal 2024.
- aTYR PHARMA INC stock issued during period, value, employee stock purchase plan for fiscal 2024 was $100.00K, a 4.76% decline from fiscal 2023.
- aTYR PHARMA INC stock issued during period, value, employee stock purchase plan for fiscal 2023 was $105.00K, a 138.64% increase from fiscal 2022.
- aTYR PHARMA INC stock issued during period, value, employee stock purchase plan for fiscal 2022 was $44.00K, a 300.00% increase from fiscal 2021.
| Period end | Stock Issued During Period, Value, Employee Stock Purchase Plan 3 month | Stock Issued During Period, Value, Employee Stock Purchase Plan 12 month |
|---|---|---|
| 2026-06-30 | $16.00K 10-Q · filed 2026-08-07 | |
| 2025-12-31 | $108.00K 10-K · filed 2026-03-05 | |
| 2025-06-30 | $79.00K 10-Q · filed 2026-08-07 | |
| 2024-12-31 | $100.00K 10-K · filed 2026-03-05 | |
| 2024-06-30 | $39.00K 10-Q · filed 2025-11-06 | |
| 2023-12-31 | $105.00K 10-K · filed 2026-03-05 | |
| 2023-06-30 | $65.00K 10-Q · filed 2024-11-07 | |
| 2022-12-31 | $44.00K 10-K · filed 2025-03-13 | |
| 2022-06-30 | $5.00K 10-Q · filed 2023-11-09 | |
| 2021-12-31 | $11.00K 10-K · filed 2024-03-14 | |
| 2021-06-30 | $5.00K 10-Q · filed 2022-11-14 | |
| 2020-12-31 | $10.00K 10-K · filed 2023-03-14 | |
| 2020-06-30 | $6.00K 10-Q · filed 2021-11-12 | |
| 2019-12-31 | $13.00K 10-K · filed 2022-03-15 | |
| 2019-06-30 | $8.00K 10-Q · filed 2020-11-13 | |
| 2018-12-31 | $36.00K 10-K · filed 2021-03-24 | |
| 2018-06-30 | $28.00K 10-Q · filed 2019-11-14 | |
| 2017-12-31 | $175.00K 10-K · filed 2020-03-26 | |
| 2016-12-31 | $143.00K 10-K · filed 2019-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B |